Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05OTL
|
||||
Former ID |
DIB008783
|
||||
Drug Name |
NW-3509
|
||||
Synonyms |
NW-3381; Sodium channel blockers (epilepsy/pain/mania), Newron
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Phase 1 | [548597] | ||
Company |
Newron pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(cccc(c1)CCNCC(=O)N(C)C)OCCCC.Cl
|
||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Blocker | [551426] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.